Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Amortization of Deferred Charges (2019 - 2023)

Historic Amortization of Deferred Charges for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Q2 2023 value amounting to $424000.0.

  • Harmony Biosciences Holdings' Amortization of Deferred Charges rose 316.3% to $424000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.7 million, marking a year-over-year decrease of 117.65%. This contributed to the annual value of $1.7 million for FY2022, which is 2569.26% down from last year.
  • As of Q2 2023, Harmony Biosciences Holdings' Amortization of Deferred Charges stood at $424000.0, which was up 316.3% from $416000.0 recorded in Q1 2023.
  • Harmony Biosciences Holdings' 5-year Amortization of Deferred Charges high stood at $1.4 million for Q4 2020, and its period low was $340000.0 during Q1 2020.
  • Over the past 5 years, Harmony Biosciences Holdings' median Amortization of Deferred Charges value was $418000.0 (recorded in 2021), while the average stood at $546533.3.
  • The largest annual percentage gain for Harmony Biosciences Holdings' Amortization of Deferred Charges in the last 5 years was 10500.0% (2021), contrasted with its biggest fall of 6997.13% (2021).
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Amortization of Deferred Charges stood at $1.0 million in 2019, then skyrocketed by 33.21% to $1.4 million in 2020, then tumbled by 69.97% to $418000.0 in 2021, then rose by 0.96% to $422000.0 in 2022, then grew by 0.47% to $424000.0 in 2023.
  • Its Amortization of Deferred Charges was $424000.0 in Q2 2023, compared to $416000.0 in Q1 2023 and $422000.0 in Q4 2022.